![](/images/Email.png)
TargetRAC-beta serine/threonine-protein kinase(Homo sapiens (Human))
Bayer Pharma Aktiengesellschaft
US Patent
Bayer Pharma Aktiengesellschaft
US Patent
Affinity DataIC50: 14nMpH: 7.5 T: 2°CAssay Description:His-tagged human recombinant kinase full-length Akt2 expressed in insect cells and activated by PDK1 was purchased from Invitrogen (part number PV 39...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)